Safety Lancet Market to Soar at a CAGR 11.8% to 2023 with Industry Top Players - F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bayer AG and Other

Safety Lancets are one of the widely used alternative device to obtain the blood samples. Lancets are receiving global recognition and acceptance due to its several convenient characteristics which gives them an edge over the traditional methods for vein puncture. Some of the important features of the safety lancets are painless vein puncture, easy handling and safety while using. The major applications of the safety lancets are capillary blood micro sampling, cholesterol test, HBO and HIV screening test, blood group test, coagulation tests, allergy tests and many other blood-based tests.

Safety Lancets are ubiquitous in applications and are widely used devices for a host of uses ranging from blood sampling, collection to incisions. The Global Safety Lancet Market is expected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 growing at a CAGR of 11.8 %.

Global Safety Lancet Market – Dominant Players

Some of the key players in this market are:

Hoffmann-La Roche AG
Becton, Dickinson and Company
Terumo Medical Corporation
Bayer AG
HTL-STREFA S.A.
Sarstedt AG & Co.
Improve Medical Technology Co. Ltd

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/550

Global Safety Lancet Market - Segments

To generate an accurate understanding of the market The Global Safety Lancet Market report has been segmented by types, end user and regions.

Based types, the market is sub segmented by pressure activated safety lancet, push button safety lancet, and side button safety lancet.

Based on end user, the market is sub segmented by hospitals & clinics, diagnostic centres and pathology laboratories, home diagnostics and other.

Based on regions, the market is sub segmented by North America, Europe, Asia Pacific, Middle East and Africa.

Global Safety Lancet Market - Regional Analysis

Europe accounts for the largest share of the market which is expected to reach USD 1,032.7 million by 2023. The European region is expected to be led by Germany, France and the U.K.

However, the market is shifting in favor of the developing countries led by China and India owing to large unmet needs and the growing number of screening and diagnostic. The development of safety regulation in healthcare is expected to result in rapid growth of the market.

North America region led by the U.S. Is expected to command faster growth than the traditional owing to compulsory testing of new-born for diseases under the affordable healthcare act.

The low health care expenditure in the Middle East and Africa regions coupled with poor socio-economic conditions in Africa will hinder the market. Thus, cost is a major value driver of the market in the African regions.

Browse Complete 87 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/safety-lancet-market-550

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.